|
⚲
|
| Keyboard |
| Thomas McNerney & Partners LLC
✚
|
|
|---|---|
| CIK # | 0001231291, 0001335196 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001231291] | |
| 4 | [0001231291] | |
| SC 13D | [0001231291] | |
| SC 13G | [0001231291] | |
| 3 | [0001335196] | |
| 4 | [0001335196] | |
| SC 13D | [0001335196] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Thomas McNerney & Partners LLC | Clarus Therapeutics Holdings Inc | [2021-12-10] |
| Thomas McNerney & Partners LP | Ocera Therapeutics Inc | [2013-07-25] |
| [2012-02-14] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 2,061,685 | $2.53 | 5,216,063 |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 5,722 | $2.53 | 14,477 |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 7,585 | $2.53 | 19,190 |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 1,164 | $2.53 | 2,945 |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 13,630 | $2.53 | 34,484 |
|
Clarus Therapeutics Inc CRXT
Common Stock
|
2022-04-20 | Sell | 1,663,126 | $2.53 | 4,207,709 |